Iindaba ezimnandi zisandula ukuvela kwiZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration yaseTshayina: uvavanyo lweklinikhi lwe-KSD-101 Injection, oluphuhliswe yiHensen Bio, luvunyiwe. Ukusetyenziswa okubonisiweyo kukusetyenziswa “kwee-tumor zegazi ezinxulumene ne-EBV ezingasabelanga kunyango oluqhelekileyo.”
Olu nyango luphucukileyo ngoku lufumaneka kwizigulana ezifanelekileyo kwihlabathi liphela ngeSebe le-**Beijing South Region Oncology Hospital International**. Sizinikele ekuguquleleni uphando lwesayensi oluphambili lube yindlela yokwelapha, sinikezela izigulana zamazwe ngamazwe ngeenkonzo zonyango eziphezulu kunye nokhetho olutsha lonyango.
I-KSD-101 sisitofu sokugonya se-dendritic cell autologous, esithathwe kwi-monocytes zabantu kwaye sigcwele ii-complexes ze-antigen ze-tumor ezinxulumene ne-EBV. Iziphumo zamva nje ezivela kuvavanyo lwayo lweklinikhi lweSigaba soku-1 ziboniswe kwiNtlanganiso yoNyaka ka-2025 ye-European Hematology Association (EHA), ebonisa amandla ayo abalulekileyo kwicandelo le-immunotherapy.
Uphononongo lweklinikhi lweSigaba soku-1 lubhalise izigulane ezineentlobo ezahlukeneyo zezifo ze-lymphoproliferative ezidibene ne-Epstein-Barr virus (EBV-LPDs), kuquka iimeko ezininzi zokunganyangeki ezifana ne-Angioimmunoblastic T-cell Lymphoma (AITL), i-Nosal-type/Peripheral NK/T-cell Lymphoma (ENKTL), i-Chronic Active Epstein-Barr Virus infection (CAEBV), i-EBV-associated Hemophagocytic Lymphohistiocytosis (HLH), i-Diffuse Large B-cell Lymphoma (DLBCL), kunye ne-Hodgkin Lymphoma (HL).
Iziphumo zophando zibonise ukuba kulandelelwano oluphakathi lweeveki ezingama-42.7, unyango olusebenzisa i-KSD-101 lukhokelele ekuxolelweni kwesifo, uninzi lwezigulane lufumana kwaye lugcina i-Complete Remission (CR). Ezi datha zinika ithemba elitsha kwizigulane ezingaphumelelanga kunyango oluqhelekileyo.
Ngokuphathelele ukhuseleko, iziganeko ezingalunganga (ii-AE) ezinxulumene nonyango yayiziimpendulo ezingephi, ezifana neempendulo kwindawo yokufakwa inaliti, umkhuhlane, kunye ne-lymphadenopathy. Akukho buthi beGrade ≥3 obubonwe, nto leyo ebonisa ukuba i-KSD-101 ayisebenzi nje kuphela kodwa ikwakhuselekile, ixhasa amandla ayo onyango lwexesha elide.
**Kutheni Ukhetha iSebe leMicimbi yeHlabathi leSibhedlele se-Oncology saseBeijing South Region?**
Njengendawo yonyango ethembekileyo kwizigulana zamazwe ngamazwe, sinikezela ngeenkonzo zonyango ezibanzi nezithetha iilwimi ezininzi zamazwe ngamazwe. Ukususela kuvavanyo lokuqala kunye nokwenza ngokwezifiso isicwangciso sonyango ukuya kulandelelwano olulandelayo, iqela lethu leengcali lizimisele ukubonelela ngonyango oluqondene nomntu ngamnye noluchanekileyo kwisigulana ngasinye samazwe ngamazwe.
Musa ukuvumela imida yeendawo ikuthintele ukufikelela kwakho kunyango olungcono kakhulu. Ukuba wena okanye ilungu losapho lwakho lihlushwa zii-tumor zegazi ezinxulumene ne-EBV kwaye alikasabela kunyango oluqhelekileyo, nceda unxibelelane nathi ngoko nangoko.
**Nxibelelana Nathi Ngoku ukuze Ufumane Uvavanyo Lwesicwangciso Sonyango**
Iqela lethu leSebe leMicimbi yeHlabathi likulungele ukukunceda. Ungasifikelela nangayiphi na kwezi ndlela zilandelayo ukuze uqale uhambo lwakho oluya kunyango oluphambili:
- ��� Ingxoxo ngefowuni: 400-880-3716
- ��� Ingxoxo yeWeChat: 17801183037
- ��� I-imeyile:
- 100085_010@163.com
- myimmnet@163.com
**ISebe leHlabathi leSibhedlele se-Oncology saseBeijing South Region**
Ithuba Lakho Lamazwe Ngamazwe Lonyango Lomhlaza
Ixesha leposi: Matshi-12-2026